Arab Canada News
News
Published: August 22, 2022
Moderna said it will supply Canada with 12 million doses of the modified COVID-19 shot targeting the Omicron variant of the coronavirus to Canada.
The Canadian government entered into a supply deal with the company last year to provide COVID vaccines for 2022 and 2023, with the contract allowing access to new vaccine modifications.
Moderna and Canada agreed to convert six million doses of the company's COVID-19 vaccine, which targets the original virus, into a bivalent vaccine containing Omicron.
Canada will also purchase an additional 4.5 million doses containing Omicron and is moving forward with the scheduled delivery of 1.5 million doses of the bivalent vaccine from 2023 to 2022.
Tuesday, 01 July 2025
--°C
--°C
Comments